Are you an asthma suffer? Manage your asthma or COPD with great ideas from people like you.Start here.
Add a Comment
In response to:
Last week, the Food and Drug Administration (FDA) listened to presentations and comments from several members of an expert FDA advisory committee regarding the benefit-to-risk ratio of Long Acting Beta-agonist drugs (LABAs) -- namely Serevent (sal...